Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

NanOthermomteRs for THeranostics

Description du projet

Des nanoparticules combinant le diagnostic par la température et la thérapie pour traiter le cancer

La théranostique est un domaine médical émergent qui utilise des nanoparticules pour diagnostiquer et traiter simultanément des maladies. L’objectif du projet NORTH, financé par l’UE, est de développer de nouveaux types de nanoparticules multifonctionnelles qui combinent le diagnostic par la température et la thérapie. Le projet propose une conception rationnelle dans le cadre de laquelle des matériaux creux, poreux, biocompatibles et multifonctionnels combineront la détection de la température et l’administration de médicaments ou thérapie photodynamique (PDT) en une seule particule. Les mesures de température ainsi que l’administration de médicaments et la PDT seront toutes contrôlées par une excitation lumineuse de longueur d’onde distincte lorsque les nanoparticules atteindront l’endroit ciblé (par exemple, les cellules cancéreuses).

Objectif

The goal of this project is to develop novel types of multifunctional nanoparticles combining temperature diagnostics and therapy. More specifically we aim at combining thermometry in the physiological range with either drug delivery or photodynamic therapy (PDT) all in a single hybrid nanoparticle constructed from Periodic Mesoporous Organosilica (PMO) with lanthanide inorganic nanoparticles grown inside the pores and/or voids of (hollow) PMO particles. For diagnostic purposes temperature measurements in biomedicine are of key importance, as temperature plays an essential role in biological systems. For biomedical applications measurements in the temperature range 20-50 ºC are essential (the so-called physiological range). Although detecting the temperature can be done employing robust, and already commercially available techniques, such as thermocouples or infrared imaging, optical temperature measurements at the nanoscale allow to reveal and study phenomena otherwise inaccessible to traditional thermometers such as measuring temperature of cells and even the organelles within them. Theranostics is a recently emerging field of interest, which combines diagnostics with therapy. In this regard, the use of nanomaterials, which allow combining multiple functions in just a single particle, would be able to change the entire healthcare scene and the way certain diseases are treated. However, with the reported up to date nanothermometer materials there is very little room to expand towards multifunctional thermometric materials. We propose a rational design where hollow, porous, biocompatible, multifunctional materials would combine temperature sensing and drug delivery or PDT in a single particle, where the temperature measurements as well as drug delivery/PDT are all controlled through separate wavelength light excitation when the nanoparticles reach the desired location (e.g. cancer cells).

Régime de financement

ERC-STG - Starting Grant

Institution d’accueil

UNIVERSITEIT GENT
Contribution nette de l'UE
€ 1 491 250,00
Adresse
SINT PIETERSNIEUWSTRAAT 25
9000 Gent
Belgique

Voir sur la carte

Région
Vlaams Gewest Prov. Oost-Vlaanderen Arr. Gent
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
€ 1 491 250,00

Bénéficiaires (1)